DK0712931T4 - Interferon-gamma-produktionsinducerende polypeptid, monoklonalt antistof og middel mod sygdomme, der responderer på interferon-gamma - Google Patents

Interferon-gamma-produktionsinducerende polypeptid, monoklonalt antistof og middel mod sygdomme, der responderer på interferon-gamma

Info

Publication number
DK0712931T4
DK0712931T4 DK95308055T DK95308055T DK0712931T4 DK 0712931 T4 DK0712931 T4 DK 0712931T4 DK 95308055 T DK95308055 T DK 95308055T DK 95308055 T DK95308055 T DK 95308055T DK 0712931 T4 DK0712931 T4 DK 0712931T4
Authority
DK
Denmark
Prior art keywords
interferon
gamma
agent
monoclonal antibody
inducing polypeptide
Prior art date
Application number
DK95308055T
Other languages
Danish (da)
English (en)
Other versions
DK0712931T3 (da
Inventor
Kakuji Torigoe
Tadao Tanimoto
Shigeharu Fukuda
Masashi Kurimoto
Shimpei Ushio
Haruki Okamura
Toshio Kunikata
Mutsuko Taniguchi
Keizo Kohno
Original Assignee
Hayashibara Biochem Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27523434&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0712931(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from JP7058240A external-priority patent/JP2952750B2/ja
Priority claimed from JP7262062A external-priority patent/JP2724987B2/ja
Application filed by Hayashibara Biochem Lab filed Critical Hayashibara Biochem Lab
Publication of DK0712931T3 publication Critical patent/DK0712931T3/da
Application granted granted Critical
Publication of DK0712931T4 publication Critical patent/DK0712931T4/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK95308055T 1994-11-15 1995-11-10 Interferon-gamma-produktionsinducerende polypeptid, monoklonalt antistof og middel mod sygdomme, der responderer på interferon-gamma DK0712931T4 (da)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP30420394 1994-11-15
JP7058240A JP2952750B2 (ja) 1995-02-23 1995-02-23 モノクローナル抗体
JP7835795 1995-03-10
JP7262062A JP2724987B2 (ja) 1994-11-15 1995-09-18 インターフェロン−γの産生を誘導するポリペプチド
JP27498895 1995-09-29

Publications (2)

Publication Number Publication Date
DK0712931T3 DK0712931T3 (da) 2001-03-19
DK0712931T4 true DK0712931T4 (da) 2006-08-21

Family

ID=27523434

Family Applications (2)

Application Number Title Priority Date Filing Date
DK99104104T DK0962531T3 (da) 1994-11-15 1995-11-10 Interferon-gammaproduktion inducerende isoleret polypeptidfragment og et isolaret DNA-fragment der koder for dette polypeptid
DK95308055T DK0712931T4 (da) 1994-11-15 1995-11-10 Interferon-gamma-produktionsinducerende polypeptid, monoklonalt antistof og middel mod sygdomme, der responderer på interferon-gamma

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK99104104T DK0962531T3 (da) 1994-11-15 1995-11-10 Interferon-gammaproduktion inducerende isoleret polypeptidfragment og et isolaret DNA-fragment der koder for dette polypeptid

Country Status (7)

Country Link
EP (2) EP0962531B1 (fr)
AU (1) AU700948B2 (fr)
CA (1) CA2162353C (fr)
DE (2) DE69535989D1 (fr)
DK (2) DK0962531T3 (fr)
ES (2) ES2156199T5 (fr)
TW (2) TW581771B (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7135458B1 (en) 1995-11-15 2006-11-14 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Interferon-γ inducing polypeptide, pharmaceutical composition thereof, monoclonal antibody thereto, and methods of use
JP4004088B2 (ja) 1995-09-26 2007-11-07 株式会社林原生物化学研究所 免疫担当細胞においてインターフェロン−γの産生を誘導する蛋白質
AU1341797A (en) * 1995-12-29 1997-07-28 Incyte Pharmaceuticals, Inc. Nucleic acids encoding interferon gamma inducing factor-2
CA2255906A1 (fr) * 1996-05-20 1997-11-27 Schering Corporation Interleukine-1j d'origine humaine et ses antagonistes
US6790442B1 (en) 1996-06-27 2004-09-14 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Genomic DNA encoding a polypeptide capable of inducing the production of interferon-γ
EP1669454A3 (fr) * 1996-06-27 2009-04-01 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo ADN génomique codant pour un polypeptide capable d'induire la production d'interféron-gamma
JPH1080270A (ja) * 1996-07-19 1998-03-31 Hayashibara Biochem Lab Inc ポリペプチドをプロセッシングする酵素
TW515843B (en) * 1996-07-25 2003-01-01 Hayashibara Biochem Lab Process for producing an active polypeptide inducing interferon-γ production
JP4024366B2 (ja) 1996-11-29 2007-12-19 株式会社林原生物化学研究所 ポリペプチド
US7141393B2 (en) 1996-12-26 2006-11-28 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Interleukin-18-receptor proteins
JP3955352B2 (ja) * 1997-02-25 2007-08-08 株式会社林原生物化学研究所 破骨細胞形成阻害剤
US6087116A (en) 1997-03-12 2000-07-11 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Interleukin-18 (IL-18) receptor polypeptides and their uses
AU741138B2 (en) * 1997-08-07 2001-11-22 Toray Industries, Inc. Canine interleukin 18, canine interleukin 1beta convertase, DNA sequences encoding the same, process for producing interleukin 18, and remedies for canine immunological diseases
EP1030681A4 (fr) * 1997-11-03 2001-07-04 Wistar Inst Methode et compositions d'inhibition de l'angiogenese et de traitement du cancer
TWI227136B (en) * 1998-05-21 2005-02-01 Smithkline Beecham Corp Novel pharmaceutical composition for the prevention and/or treatment of cancer
AR022952A1 (es) 1999-03-19 2002-09-04 Smithkline Beecham Corp ANTICUERPO MONOCLONAL DE ROEDOR ESPECIFICAMENTE NEUTRALIZANTE PARA LA INTERLEUQUINA-18 HUMANA , UN FRAGMENTO FAB NEUTRALIZANTE o FRAGMENTO F(AB')2, UNA REGION DE COMPLEMENTARIEDAD DE CADENA LIGERA DE INMONOGLOBULINA(CDR), UNA MOLECULA DE ACIDO NUCLEICO, COMPOSICION FARMACEUTICA QUE LO COMPRENDE, EL
US6432678B1 (en) * 1999-06-21 2002-08-13 Smithkline Beecham Corporation Macaca cynomolgus IL 18
EP1257585A2 (fr) 2000-02-10 2002-11-20 Basf Aktiengesellschaft Anticorps de liaison de l'interleukine 18 humaine et procedes de preparation et d'utilisation
GB0009503D0 (en) * 2000-04-17 2000-06-07 Univ Liverpool Screening method for compounds
AU2001275166B2 (en) * 2000-06-02 2005-07-28 Smithkline Beecham Corporation Methods of treating viral diseases with il-18 and il-18 combinations
CZ20024085A3 (cs) 2000-06-15 2003-05-14 Smithkline Beecham Corporation Způsob přípravy fyziologicky aktivního IL-18 polypeptidu
TR201809008T4 (tr) 2001-06-26 2018-07-23 Amgen Fremont Inc Opgl ye karşi antikorlar.
WO2003057821A2 (fr) * 2001-10-26 2003-07-17 Centocor, Inc. Proteines et anticorps mut-il-18 or mut-il-18r, compositions, procedes et utilisations
PL378879A1 (pl) 2002-12-30 2006-05-29 Amgen Inc. Terapia skojarzona z czynnikami kostymulującymi
JP4753867B2 (ja) 2003-04-15 2011-08-24 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー ヒトｉｌ−１８を含むコンジュゲートおよびその置換変異体
US20050100965A1 (en) 2003-11-12 2005-05-12 Tariq Ghayur IL-18 binding proteins
US7968684B2 (en) 2003-11-12 2011-06-28 Abbott Laboratories IL-18 binding proteins
AU2005277404A1 (en) 2004-08-20 2006-03-02 Smithkline Beecham Corporation Methods of healing wounds by administering human IL-18
TWI422387B (zh) 2006-05-25 2014-01-11 Glaxo Group Ltd 免疫球蛋白
AR065803A1 (es) 2007-03-23 2009-07-01 Smithkline Beecham Corp Uso de un polipeptido de il- 18 humana y un anticuerpo anti- cd para preparar unmedicamento
US8168165B2 (en) 2008-12-23 2012-05-01 Abbott Laboratories Alkylated interleukin-18 compositions
EA201290630A1 (ru) 2010-02-09 2013-03-29 Глаксо Груп Лимитед Лечение расстройства обмена веществ
JOP20200308A1 (ar) 2012-09-07 2017-06-16 Novartis Ag جزيئات إرتباط il-18
CA2957387A1 (fr) 2014-08-07 2016-02-11 Hyogo College Of Medicine Agent therapeutique contre le cancer contenant une combinaison d'il-18 et d'anticorps de ciblage de molecules

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5457038A (en) * 1988-11-10 1995-10-10 Genetics Institute, Inc. Natural killer stimulatory factor
JP3230531B2 (ja) * 1991-08-08 2001-11-19 光信 佐藤 ＩＦＮ―γ誘導活性物質
DE69519454T2 (de) * 1994-07-14 2001-05-03 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo, Okayama Protein, das Interferon-Gamma Herstellung induziert und monoklonaler Antikörper dagegen

Also Published As

Publication number Publication date
ES2156199T5 (es) 2006-12-16
DE69535989D1 (de) 2009-09-17
DE69520088T2 (de) 2004-07-29
DK0712931T3 (da) 2001-03-19
EP0712931B1 (fr) 2001-02-14
EP0712931A3 (fr) 1997-03-26
DE69520088D1 (de) 2001-03-22
ES2329099T3 (es) 2009-11-20
EP0962531B1 (fr) 2009-08-05
TW581771B (en) 2004-04-01
EP0962531A2 (fr) 1999-12-08
ES2156199T3 (es) 2001-06-16
AU3779695A (en) 1996-05-23
AU700948B2 (en) 1999-01-14
CA2162353C (fr) 2010-04-27
DK0962531T3 (da) 2009-10-05
EP0962531A3 (fr) 1999-12-15
DE69520088T3 (de) 2006-11-23
TW464656B (en) 2001-11-21
CA2162353A1 (fr) 1996-05-16
EP0712931B2 (fr) 2006-04-19
EP0712931A2 (fr) 1996-05-22

Similar Documents

Publication Publication Date Title
DK0712931T4 (da) Interferon-gamma-produktionsinducerende polypeptid, monoklonalt antistof og middel mod sygdomme, der responderer på interferon-gamma
NO980915L (no) Rekombinante anti-CD4-antistoff egnet for human terapi
NO910923D0 (no) Trifunksjonell antistofflignende forbindelse som et kombinert diagnostisk og terapeutisk middel.
BR9504791B1 (pt) composto de polipeptìdeo e composição farmacêutica.
NO307707B1 (no) Spiroazabicykliske forbindelser, farmasøytisk preparat inneholdende slike forbindelser og anvendelse derav
NO894228D0 (no) Tienopyridiner, fremstilling, mellomprodukter og farmasoeytiske preparater.
DK597288D0 (da) Rekombinant, humant immunoglobulin og fremgangsmaade til fremstilling deraf
DK0605442T3 (da) Rekombinante antistoffer til human terapi
NO972451D0 (no) 2-heterocyklyloksy og tiometyl-1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og fremgangsmåte for anvendelse derav
NO922155L (no) Peptider og antistoffer som inhiberer integrinligandbinding
NO891334D0 (no) Supraledende material og fremgangsmaate for dets fremstilling.
NO843294L (no) Monokloklonat antistoff, dets fremstilling og anvendelse
DK224985D0 (da) Peptider, og midler indeholdende peptiderne
NO891006D0 (no) Terapeutisk aktivt polypeptid og fremgangsmaate for dets fremstilling.
NO995062L (no) <Beta>-anyloidpeptid-bindende proteiner og polynuldeotider som koder for samme
NO893892D0 (no) Antimikrobiologisk sammensetning og fremgangsmaate for anvendelse.
TR199501542A2 (tr) Bagisiklik önleyici aktiviteye sahip monoklonal antikor parcalari.
DK43489A (da) Immunotoksin og fremgangsmaade til dets fremstilling
NO893474D0 (no) Flammehemmende midler og fremgangsmaate for anvendelse.
DK270386D0 (da) Monoklonalt antistof til humant protein c, dets fremstilling og anvendelse
DK8089A (da) Monoclonale antistoffer, deres fremstilling og anvendelse.
NO911837D0 (no) Framgangsmaate og anordning for punktsveising.
DE69434900D1 (de) Menschliche chemokin-polypeptide
DK0391407T3 (da) Polypeptid og antibakterielle præparater, der indeholder det
BR9709080A (pt) Anticorpo monoclonal anti-MP52 humano